Newcomer Partner Therapeutics Nabs $60M, Acquires Leukine From Sanofi Post author:Sam Post published:January 31, 2018 Post category:BioPharma Only a week after launch, Partner Therapeutics acquired the global rights to Leukine from Sanofi. Source: BioSpace You Might Also Like UK Charity to Use $638 Million Cash From Merck & Co.'s Blockbuster Keytruda to Back R&D June 14, 2017 Roche Reprioritizes Pipeline, Kicks Leukemia and Lung Cancer Drug Med Back to ORYZON Genomics July 19, 2017 Vexim Strengthens Its Intellectual Property Protection For The SpineJack In Asia: Two Patents Granted In China And Japan February 1, 2017
UK Charity to Use $638 Million Cash From Merck & Co.'s Blockbuster Keytruda to Back R&D June 14, 2017
Roche Reprioritizes Pipeline, Kicks Leukemia and Lung Cancer Drug Med Back to ORYZON Genomics July 19, 2017
Vexim Strengthens Its Intellectual Property Protection For The SpineJack In Asia: Two Patents Granted In China And Japan February 1, 2017